TMC Life Sciences Publishes 2026 Corporate Governance Report

• TMC Life Sciences extended its 5% Scope 1 and Scope 2 emissions reduction timeline in its governance report for fiscal 2026.
• The target now spans five years from fiscal 2025, versus three previously, aligning with its parent company's sustainability target.
• Independent directors hold four of six board seats; women account for 33% of directors.
• No independent director has served beyond nine years, though the board has not adopted a policy barring extensions beyond that limit.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TMC Life Sciences Bhd published the original content used to generate this news brief via Bursa Malaysia (KLSE) (Ref. ID: 3717894) on October 23, 2026, and is solely responsible for the information contained therein.